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ABSTRACT 
In this paper we present an extension of an automata approach proposed by S. Blower (1998) to describe the 
tuberculosis progression in a bi-dimensional space. In our extended model, the vaccination was included as an 
inhibitory variable in order to study its influence on the behavior of the tuberculosis spread. Our simulations 
showed that the earlier the vaccine is administered in the population, the lower the number of infected 
individuals, as expected for an in vivo system. However, our results also indicated that although the usual 
vaccination processes help reducing the strength of infection, the disease is not extinct, remaining the endemic 
state at low levels. These results strongly suggest that further actions are needed to increase the effectiveness of 
immunizations. 
Keyword: Simulation, epidemic, tuberculosis, cellularautomata. 
 
I. INTRODUCTION 
Tuberculosis (TB) is an important health issue 
for Brasil and many others around the world. It is 
estimated that about one third of the world population 
is already infected with tuberculosis (Mtb). Each year 
8.8 million new cases are reported [18]. TB is a 
disease that over the years has been concerning the 
world society, it has high risk of infection and 
contagion. A person infected is able to infect around 
10 to 15 people over a period of one year [2]. The 
Mtb infection can be transmitted by coughing, 
sneezing, singing, speech, breathing, and even by 
tracheotomy individuals. This is a slow-developing 
disease, which in most cases occurs after two years 
after initial infection. The advent of vaccination with 
BCG and with increasing effectiveness of treatment 
reduced the chronic disease and its transmission in 
this community.  
The treatments are in permanently evolution in 
past 50 years they were able to change the face of the 
disease appearance, move to the third age. The 
immunity occurs with the primary contact with the 
bacteria and vaccination, reduces susceptibility to 
infection, making the state of the population switch to 
the recover state, during until the immunity falls. 
Previous studies show that the immune response 
given by the vaccine in people already sensibilized 
by the Mtb from a primary infection does not bring 
an improvement in protection [19]. Some authors 
state that the main effect of BCG is to reduce disease 
progression more than the actual risk of infection 
(Smith et al. 2000). In order to help health services, 
indicating the crow of the disease, the advance in  
 
some neighborhood and indicate the epidemiological 
emergence, showing where it emerges, helping the 
decision making to becoming more dynamic to solve 
the potential problem. With this purpose was 
developed interdisciplinary urgent action, which has 
a bio-mathematical models and computer simulation 
dynamics. The idea of a dynamic model that is 
formed based on discrete time and consists of a 
spatial grid of cells filled in time and space [16]. In 
most cases, the classical models (SIS, SIRS or 
SEIRS) with transmission rate and population 
constant, present a unique endemic equilibrium. This 
paper shows the effectiveness of BCG vaccination in 
individuals of different age groups, studying the 
dynamics of tuberculosis in these people. 
 
II. METODOLOGY. 
In orderto developaprobabilisticcellular automata 
model, represented inacomputational grid where each 
cell representsanindividualandits location. This 
personisendowed withastatusthatgives itsplacein the 
dynamics. The epidemicdissemination can 
beconsideredas aset ofstatesdescribedas 
follows:Susceptible(hoping toget infected), 
latent(infected butwith the bacteriaunder control), 
Infected(bacteria activelytransmitsthedisease) 
Recovered(immune to disease) 
andifimmunityislowyou cango backto 
thestateSusceptible(when 
passinghasimmunityinsomecases) (SEIRS) [5]. 
Thediagramoftransition between statesis 
representedinFigure 1 
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Figure 1: SEIR state model with vaccine, where is 
the Power of infection, is the recovery rate, is the 
rate of infection and is the mortality rate, is an 
adaptation of  BLOWER, SM, 1998 model. 
Source: BLOWER, SM, et all, 1998. 
The main feature of the used model is the ability 
to develop locally. Since the tuberculosis bacillus 
needs necessarily of an direct and prolonged contact, 
since the disease develop slowly a concern should be 
taken in the model. The first infection may manifest 
in months or years. The global transmission exists, 
but is uncommon. For people from the same 
population, has the capacity of global transition is 
given by the total number of infected individuals in 
the network, due to their ability to walk (pG), is 
described by the equation: 
ProbGlobal = *(TS_Total + TR_Total)/N; 
where 0≤ ρ≤1  (1), where TS are the susceptible 
infected people, the TR are the resistant infected, the 
N is the total number of individuals in the grid and 
and  are parameters used for small (forming 
clusters) and long distance (mean field) [9], knowing 
that pL>>pG. 
To influence the population who lives around of 
a infected individual, local spread (pL), being its 
ability of infect given by the equation 2, where 
ProbTypeS is the probability to susceptible infected 
pass the illness: 
 pL = 1.0 - (ProbTypeS + ProbTypeR - 
ProbTypeS*ProbTypeR). Where:  
 ProbTypeS = 1.0 - pow(1.0 - lS, CountTS); 
 ProbTypeR = 1.0 – pow (1.0 - LambdaR, 
(double)CountTR). 
Wasusedto describe theindividualbehavior with 
his neighborhood theMooremodel, whereaperson is 
abletogetin contactwitheveryone around, the 
probalility ofinfection isgiven byequation2. 
Thedynamicsis givenas follows, the 
infectedindividualaccount the number of infected 
neighborsand look for the susceptible. From 
therewithacertain probabilitypL=1-(1-λ)n, 
wherenisthenumber ofinfected individuals,passes 
intoa latent 
state.Withaprobabilityv,whichrepresentstime, 
socioeconomic,environmental and stateof 
immunity,the susceptible individualbecomesinfected, 
infectedaftertreatmentwelldone become 
recoveredclosingthechain. 
 
III. RESULTS. 
The simulations represented in this article 
demonstrate the TB behavior when submitted to 
interventions. The control parameters of bacilli 
spread were studied and taken from an mean of the 
Brasilian govern database and from others articles so 
the amounts should be approximate real life. The data 
simulated wore compared with the literature 
verifying the model efficacy.  
In the figure 2 show that inspire of the vaccine 
has a significant importance for the primary 
tuberculosis prevention and some importance for 
pulmonary TB, the BCG is not able to put away the 
danger, letting the disease always at endemic state, 
only ranging the number of infected people. Was 
studied the vaccine in different levels of efficacy, 
35%, 65% and 85%.When the efficacy of vaccine 
was putted at 90% of efficacy, but now was changed 
the time of shooting to: 1st, 10, 40, 80 years of the 
simulation, with or without the treatment or 
chemoprophylaxis. The results show that by 
increasing and decrease the efficiency, changing the 
date of the shooting not only decreases the level of 
infection, but also alter the life of the vaccine, how 
long protection lasts increases. Can be seen that the 
greater efficacy in vaccine and lower the age at which 
it applies the vaccine has a less variation between 
peaks and valleys, thus reducing the likelihood of an 
outbreak due to another event, such as opportunistic 
infections. 
Once the vaccine is not only able to end the 
pathogen, the only way to eradicate the disease is 
thought the treatment, the treatment was used at a phi 
of 0.1 and 0.5 sigma, which are respectively the per 
capita rate of treatment and the rate per capita of 
chemoprophylaxis, used for third world countries, a 
number of treaties of 70% and 50% in 
chemoprevention, we studied with and without 
vaccine, 90% of the population were vaccinated and 
the vaccine efficiency was 85% and still dividing at 
ages of vaccination, 5 , 10, 20 and 50 it can be shown 
at the figure 1b. 
The figure 3 show a treatment applied in some 
time after or before the year 5, 10, 20 and 50. This 
particular study shows that the disease is not 
completely, the epidemic wave drops, but the 
sickness continue in the endemic 
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way in low level. If vaccine is used perceives 
that the number of infected people levels drops even 
more but only when the shots are made between 0 
and 5 years that the TB tends to disappear, but it 
doesn’t.  The figure shows too that if the vaccine is 
applied exactly at the first years, 0,1, 2, 3, 4 and 5 
percent ofvaccinated people are greater than 85% and 
counting with a good treatment that’s  possible to 
exterminated the tuberculosis in the finite population. 
Figure 2 – Tuberculosis time evolution, (a) Vaccine 
with 35% of efficacy, administrated in the 1
o
ano, 
10
o
ano, 40
o
ano e 80
o
ano. (b) Vaccine with 65% of 
efficacy, administrated in the 1
o
ano, 10
o
ano, 40
o
ano e 
80
o
ano. (c) Vaccine with 85% efficacy, administrated 
in the 1
o
ano, 10
o
ano, 40
o
ano e 80
o
ano. (d) Show the 
contrast between the tree efficacy’s at the first year. 
Figura 3 - Time evolution of tuberculosis, with a 
90% percentage of vaccinated and 85% of vaccine 
efficacy. (a) Treatment in the 5th, the first 5 years 
and after 5 years, with or without vaccine. (b) 
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treatment in the 10th, the first 10 years and after 10 
years, with or without vaccine. (c) Treatment at the 
20th, the first 20 years and after 20 years, with or 
without vaccine. (d) Treatment at the 50th, the first 
50 years and after 50 years, with or without vaccine. 
 
IV. DISCUSSION 
In the tuberculosis time behavior study, taking 
into account the age, gender and socioeconomic 
customs, this study aimed to verify the effectiveness 
of BCG as a prophylactic measure. By successive 
simulations using different vaccine efficacy, 
vaccinating at different ages and finally using the 
treatment. It can be seen that although the efficacy 
has a little influence on the performance of the 
disease, is able to reduce the force of infection, due 
to, once vaccinated the chances of getting infected 
diminishes. 
Figure 1 focuses on the different rates of vaccine 
efficacy, 35%, 65% and 85%, with age vaccination, 
1, 10, 40 and 80. The results shows that in the first 
year is was found the best immune response to 
vaccine. According to the Andersen study, 
vaccination of the newborn, which in our system 
represents the first year, is where the greatest relation 
age and vaccine efficacy (Andersen, 2007). So it was 
simulated for different efficiencies and different ages 
and finally settled the prime age, ranging only the 
vaccine's effectiveness. Thus it was realized that only 
with the variation in vaccine efficacy is not enough to 
achieved a significant improvement, the treatment is 
necessary to break down the disease cycle. 
The finding is in agreement with the Andersen 
(2005), which questions the real effectiveness of the 
vaccine, showing that the protective performance of 
BCG decays with the coming years to maximum 10 
to 20 years of protection. When dealing with efficacy 
of the vaccine in graph 2, it was explored between 35 
and 85%, since there are reports suggest an efficacy 
of BCG for 0 to 80% (Pereira et al., 2007). 
BARRETO, (2006), reports that the power of BCG 
action varies from 0 to 86%, this variation may be 
caused due to the characteristics of the individual, 
their habitat, the strain of the bacillus among others. 
The finding that underscores the controversy about 
the efficacy of BCG, since there was no great 
difference in different efficacies after 85% 
(SUGAWARA et al, 2009). 
Regarding vaccination coverage in this paper we 
used a coverage of 90% of individuals are vaccinated, 
this number varies with the environment, town and 
over the years in a given population. MIRANDA et al 
(1995) suggested that BCG vaccination coverage 
varies from 79 to 85%. MORAES et al (2003), 
reports that the coverage of BCG in the metropolitan 
region of Sao Paulo reaches 97.8%. 
YOUNG, et al (2008) talks about the association 
between the BCG efficacy and the body's own ability 
to reject the disease without any intervention, since 
only 10% of the diseases manifests in its active form. 
In the same study was called into question the real 
effectiveness of the vaccine against pulmonary 
tuberculosis. 
BIERRENBACH, et al. (2007) study is in 
agreement with the work proposed here, once the 
vaccine is applied the frequency of new cases of 
tuberculosis decrease mainly in the in the simulation 
first years, after some time the new cases of the 
disease start to grow back and If that is not properly 
treated, the disease itself stabilized and becomes 
endemic. However, with a high rate of infected 
people or the contraction of immune depressor 
sickness represents a major risk for the resurgence 
and possible development of an epidemic outbreak. 
RUFINO (1977) reports that with at least 55.5% 
BCG efficacy it would be enough to keep the 
relationship economy – spending. According to the 
study proposed the vaccine is not able to replace the 
treatment, even with a 100% efficacy vaccine. In the 
literature can be seen that the efficacy of BCG varies 
from 50% to 87% (BARRETO, et al, 2006; SHEN, et 
al, 2008), it shows that the BCG that is produced 
today is not sufficient to snuff out the bacillus.  
VASCONCELOS et al (2009) describes the 
ineffectiveness of BCG for preventing pulmonary 
TB, which is in agreement with our findings. 
However, the author reports on his study that in the 
process of developing a new vaccine against 
tuberculosis, which will be effective against 
secondary tuberculosis, would be a big step toward 
the end of tuberculosis.  
However is  possible to see in the result, in the 
first phase of tuberculosis plus the use of vaccine 
shows a substantial decline, this drop was already 
observed by ALMEIDA (1990) in his study that 
compared the mortality occurring in children under 1 
year, before and after vaccine, showing that there is a 
regression from 7.9 times after the vaccine. This 
demonstrates that the protection afforded by the 
vaccine is in the first life age. 
FU (2002) shows a historical evidence that in a 
population where individuals go through a network, 
either a city or a country, there is a chance that an 
infection after an outbreak will become endemic. Our 
findings corroborate this claim, since the tuberculosis 
disease always tends to be endemic in the state, 
according to the proposed model. 
The figure 2 shows the endemic characteristic of 
tuberculosis, which remains throughout its existence, 
to looking at the figure 2 it’s clear to see that the 
natural trend of tuberculosis over time is shown in 
linear average, this means that there are a outsized 
changes in its etiologic characteristic, unless 
something goes in advent that will strengthen the 
Mycobacterium Tuberculosis (Andersen, 2007). 
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The disease manifests as a tendency in many 
endemic countries, with a higher incidence in 
developing countries, that is the case of Brazil, 
affecting 10% to 15% of immunocompetent patients 
and 50% to 70% of individuals with acquired 
immunodeficiency syndrome (RIQUELME , 2006). 
By observing the second figure it is clear that 
Mycobacterium tuberculosis is no longer follow its 
natural tendency, stabilized, it can happen by 
feedback, genetic and environmental factors, the 
infection requires a long time relied on the bacterium, 
fee high virulence, and hostile conditions of life, 
which makes the transmission and spread, giving the 
human body able to make the first fight the disease 
(PENNA, 1988). 
Tuberculosis is an injury that the environment 
itself gives man a natural vaccine, characterizing the 
stability of the disease without the presence of any 
adverse condition, the HIV can change the constancy 
of the disease and enhances the risk of developing 
active TB (KERR-BRIDGES, ET all., 1997). 
GLYNNA (1997) and Vasconcelos (2009), talk about 
how leprosy and HIV are considered extremely 
dangerous to be related to tuberculosis, are largely 
responsible for its appearance and / or resurgence, 
and that the combination of BCG vaccine in people 
with immunosuppression can be very dangerous. 
Confirming the hypothesis of this study in which 
only the associate diseases that depress the immune 
system are able to take the trend of endemic TB. 
Figure 1 shows the trend of tuberculosis in time 
for a vaccinated population in year 1, 10, 20, 40 and 
80, with an efficiency of 35%. The choice of vaccine 
efficacy for this experiment was made because is a 
low percentage, and it is in agreement with the 
variation of effectiveness according with (PEREIRA 
et al., 2007). With an effective so low it is clear that 
the spread and stabilization, are not much different 
for all ages. In the first years of life, 0 to 5 years, can 
be observed the highest percentage of BCG 
effectiveness, 84%, making the choice of one year as 
the key year for the best use of the drug. The 
variation in vaccine efficacy also suggests the age 
difference in a population where the highest 
efficiency is obtained in the first five years of life 
with a protection given to 85% to 87%, however over 
the years the protective effect decreases. 
Over the years as seen in the figure 2 the 
effectiveness begins to decrease, which leads us to 
choose the 10th year since between the ages, 1 and 15 
years the BCG efficacy drops about 59%, proving 
what was suggested in the resuts (Barreto et all, 
2006). In this trend the vaccine administrated in the 
years 20 and 40 shows a higher degradation in its 
protective effect, combined with the worst habits of 
life of a young population, cases of tuberculosis 
increasing in this age group. From the age of 50 
despite the older population better watch out, your 
body, the defense no longer works as before, their 
effectiveness drops to lowest index to measure the 
mortality rate increases, Wales (1998), discusses the 
growth of the adults deaths for young people between 
20 and 49, representing 59.7% of deaths and the 
decline in deaths to less than 20 and greater than 50 
years. 
SHEN et al (2008) presents in his paper that not 
only has the vaccine more effectiveness when 
younger, but also the duration of its protective effect 
last longer, as suggested in the paper. The attenuation 
of immunity caused by BCG, decays with time as 
evidenced by this hypothesis DOHERTY (2005) that 
shows even with the continued reduction of the 
protective effect conferred by BCG vaccination 
compromises the body ability to stimulate production 
of antibodies and immune memory. 
The treatment is taken as the only way to really 
remove the bacillus of the human body system, but 
only with a treatment well done from start to finish. 
Jasmer et al (2004), describes in his article that 
treatment well made, properly led from the beginning 
to the end represents a healing capacity of over 
97.5% of cases and also alerts on the problem of 
treatment abandonment which gives strength to the 
mycobacterium tuberculosis making it more 
resistant and difficult to treat. VALLEJO (1994) calls 
attention to the fact that if the treatment is done 
correctly and has sooner start it can be a cure in about 
six months, explaining the sharp drop shown in figure 
3 where the processing is done with efficiency and 
accuracy. 
The figure 2 shows the tuberculosis in time with 
and without vaccine, at the ages already mentioned in 
this discussion, but at this time was add the treatment 
as well. As seen in this work the BCG is not able to 
suppress the bacillus, so the treatment is necessary to 
cease the illness, since only effective treatment is 
able to eliminated it (Andersen, 2005). The figure 
portrays the treatment of individuals, minor and equal 
to 5 years old, using the fifth year as reference. In this 
discussion it was resolute that at the ages 0-5 is 
where can get the best results for contraceptive 
measures. Was also used in this simulation the 
treatment well done and ineffective treatment, a 
treatment that was not completed, the incomplete 
treatment reflects a major problem for public health, 
since the bacillus becomes resistant to drugs (LIMA 
et al, 2001). 
The settled treatment on the year fifth can be 
called an early treatment, as it is done in children has 
a good adhesion, making it the fastest and safest 
treatment (LIMA et al, 2001; Perreira et al, 2007). It 
can be seen that within an increasing age makes the 
treatment with or without vaccine, with a well done 
treatment, ruled at any age the real improvement 
occurs. The vaccine can help a bad treatment, 
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however it appears an increase of infected individuals 
resistant. 
In his study Koriki (2008) reports that at the 
equilibrium, endemic, the tuberculosis is able to 
change your state depending on external conditions, 
as associated diseases, differences in climate, 
inhospitable regions, as well as the population 
socioeconomic level. This information goes in 
agreement with was showed on the results obtained 
in this work. In its endemic form, the infection only 
can become active with a disturbance in the disease 
routine.  
 
V. CONCLUSION. 
The proposed model was used to aid and check 
the decision making regarding to the epidemiology of 
tuberculosis. The results showed in this paper were 
satisfactory and from them we can infer that: 
 The BCG has great accuracy and effectiveness 
for populations of individuals between the ages 0 
to 5 years. After this age the vaccine's 
effectiveness begins to wane.  
 The vaccine is not able to influence the spread of 
pulmonary tuberculosis, showing that BCG is the 
way you made today has a positive effect, ending 
only with severe forms of primary tuberculosis.  
  Since the vaccine reduces slightly the amount of 
infected individuals in the network, the treatment 
is necessary, only the treatment is done properly 
able to shoot with tuberculosis. 
 Poor treatment generates dangerous 
consequences, makes the multi resistant bacillus. 
The above study did not focus on MDR, but 
future work will be given greater attention to this 
issue.  
This study is very important to create a 
discussion, since it will provide a different 
perspective and depth on the observed behavior of 
the disease in question. The results of the works show 
the reality of tuberculosis in Brazil as well as their 
way of life, this indicates that the model can be used 
to simulate the behavior of many tuberculosis 
situation satisfactorily. This way you can monitor and 
study the TB from the proposed system.  
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